Capital Investment on Our Drug Development Journey

Icon_Sun.svg The Road to BIO: Day 3

Saturday, June 10, 2017
Pennsylvania /// Tennessee


We're three days into the Road to BIO, but for some reason it feels like it's really kicking off today. After spending the first two days navigating around Massachusetts, Connecticut, New York, New Jersey and Pennsylvania, we are finally breaking out of the northeastern corner and making our way south.   

Grand Lobby

This morning we’re heading toward the nation’s capital, Washington DC, on The Road to BIO. We’re planning a stop at a Lamborghini dealer in Virginia later to get a health check for the car. Meanwhile, we’re taking in some of the district’s landmarks including The White House, Capitol, and Washington Monument. As well as being surrounded by plenty of biopharm in neighboring States, Washington is where the lobbying happens and it’s home to many associations, including the Biotechnology Innovation Organization (BIO).

DISTANCE SCHEDULED THIS MORNING: 170 miles

Thursday Afternoon Recap

After kicking off #RoadtoBIO in Boston on Thursday morning, our progress began its long path southwest with a sponsor company visit in Connecticut, which highlighted its state commitment to innovation by ranking fourth nationally for patents per 1,000 people in 2016. 
 
Our last stop on Day 1 was a welcome evening visit to the Tea & Sympathy restaurant in New York City, who kindly fed our hungry road trip crew a British fish’n’chip supper from their authentic takeout, #asaltandbattery. It also gave us the opportunity for a first roving interview on healthcare in the US. Our sincere thanks to our good friends and owners of @teaandsympathy, Nicky Perry and Sean Kavanagh-Dowsett.

R2B_TN_0610_AM5.jpg

We'll check back in this afternoon from Virginia with more #RoadtoBIO updates on our journey toward #BIO2017 

R2B_TN_0610_AM2.jpg
Sven Lee, Chief Business Officer for Abzena, is pictured here at Abzena’s Bristol, PA site, which was named “Best CRO” at World ADC in 2016

R2B_TN_0610_AM4.jpg
Matthew Kennedy, Process Specialist, Senior Associate for CRB, talks best practices and innovative technologies leveraged in CRB’s FutureFacility™ to address biomanufacturing challenges

R2B_TN_0610_AM6.jpg
Kristine K. Senft, pharmaceutical and chemical sales and marketing executive, discusses developing an effective marketing strategy to reach multiple segments across the industry
 

To join us on the Road to BIO, view all of our daily videos.

 

TN_Booth.gif

Steve Kuehn

Steve offers the life science industry insight and perspective from his more than 30 years of editorial, corporate and agency communications experience. Drawing from tenure as a lead communicator and media relations director for one of world’s largest technology and engineering companies, as well the editorial leadership of industry-leading B2B journals serving the energy, transportation and pharmaceutical sectors, including Pharmaceutical Manufacturing magazine, Steve delivers brand strategy, market-moving content and decision support. Steve holds a Bachelor of Science degree from Ohio University.

Q: